Innovator Laddered Allocation Power Buffer ETF

Q3 net sales increased 18.4% year over year, driven by 9.8% volume, 8.3% mix, and 0.3% pricing. Gross margin was 47.2%, up 90 basis points from last year. Adjusted net income was $53 million, up 19.1%, and adjusted diluted EPS was $0.27, up 19.6%. Full-year 2017 guidance was raised to net sales of $1.250 billion-$1.265 billion and adjusted EPS of $0.91-$0.93; the full-year tax rate is expected to be 36.4%-36.9%, and CapEx is expected to be $150 million-$170 million.

Billy Bishop framed the quarter as proof that Blue Buffalo is gaining share, strengthening its brand, and expanding its addressable market through a selective push into food, drug and mass. He emphasized that the company feeds less than 3% of pets today, so broader distribution is a major long-term opportunity, and said the company is taking a thoughtful, quality-of-distribution approach rather than rushing the rollout. His tone was upbeat but measured, repeatedly saying the team is encouraged, learning from early FDM execution, and still focused on becoming a major player in the channel.

Mike Nathenson highlighted the quarter’s mix of strong revenue growth and margin expansion, with gross margin at 47.2% despite higher warehouse and distribution costs from the FDM expansion. He said SG&A grew 20.5% excluding equity-offering and litigation costs, reflecting increased advertising and other revenue-generating investments, and that year-to-date operating cash flow less CapEx was $50 million with $308 million of cash on the balance sheet. He also noted $72 million of CapEx year to date, completion of the $50 million share repurchase program, and reiterated that the FDM launch creates some near-term distribution headwinds but should eventually yield productivity benefits.

Analysts focused on whether FDM share gains were slower than expected, whether the rollout would be fully distributed by year-end 2018, and how much of the new-channel sales were incremental versus cannibalizing specialty. Management said the 5% to 6% share path reflects later-than-planned footprint expansion in some accounts, that the initial FDM sales look largely incremental so far, and that 2018 guidance would be provided on the next call. They also said specialty sell-in was pressured by retailer caution, reduced off-shelf activity, and canceled promotions, but sell-through remained stronger at 7% and early Q4 ordering had normalized somewhat.